Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses. 2006

James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
Department of Medicine, VA San Diego Healthcare System and the University of California, San Diego, La Jolla, California 92093-0676, USA.

9-(S)-(3-Hydroxy-2-phosphonomethoxypropyl)adenine [(S)-HPMPA] was one of the first acyclic nucleoside phosphonates described and has been reported to have good antiviral activity against most double-stranded DNA viruses, including the herpes group viruses and the orthopoxviruses. However, (S)-HPMPA is not orally bioavailable and has not been developed for clinical use. We have prepared orally bioavailable lipid esters of (S)-HPMPA and report their synthesis and antiviral evaluation against cytomegalovirus and orthopoxviruses. These esters were evaluated in vitro in cells infected with human cytomegalovirus (HCMV), murine cytomegalovirus (MCMV), vaccinia (VV), and cowpox viruses (CV). The most active compound, oleyloxyethyl-(S)-HPMPA, was found to have EC50 value of 0.003 microM against HCMV vs 1.4 microM for unmodified HPMPA. In cells infected with VV and CV, octadecyloxyethyl-(S)-HPMPA had EC50 values of 0.01-0.02 microM versus 2.7-4.0 microM for unmodified HPMPA. When compared with the alkoxyalkyl esters of cidofovir, the corresponding alkoxyalkyl esters of (S)-HPMPA were equally active against HCMV and MCMV but were 15-20-fold more active against VV and CV in vitro. The alkoxyalkyl esters of (S)-HPMPA are promising new compounds worthy of further investigation for treatment of infections caused by herpes viruses and orthopoxviruses.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D018155 Orthopoxvirus A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS. Camelpox virus,Horsepox virus,Raccoonpox virus,Skunkpox virus,Taterapox virus,Volepox virus,Camelpox viruses,Horsepox viruses,Orthopoxviruses,Raccoonpox viruses,Skunkpox viruses,Taterapox viruses,Volepox viruses,virus, Camelpox,virus, Horsepox,virus, Raccoonpox,virus, Skunkpox,virus, Taterapox,virus, Volepox
D063065 Organophosphonates Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P Phosphonate,Phosphonates,Phosphonic Acid Esters,Acid Esters, Phosphonic,Esters, Phosphonic Acid

Related Publications

James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
May 2011, Bioorganic & medicinal chemistry,
James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
November 1992, Biochemical pharmacology,
James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
July 2006, Antimicrobial agents and chemotherapy,
James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
December 2009, Antiviral research,
James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
July 2009, Antimicrobial agents and chemotherapy,
James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
October 1992, Journal of medicinal chemistry,
James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
November 2000, Journal of medicinal chemistry,
James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
January 1987, Nucleic acids symposium series,
James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
December 2003, Antimicrobial agents and chemotherapy,
James R Beadle, and William B Wan, and Stephanie L Ciesla, and Kathy A Keith, and Caroll Hartline, and Earl R Kern, and Karl Y Hostetler
December 2003, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!